2025 annual financial data
Eton Pharmaceuticals 2025 Operating margin
Eton Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was 0.09%.
Operating income was 72,000 USD and net income was -4,601,000 USD.
Operating cash flow was 10,524,000 USD.
Get free Eton Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 79,950,000 USD
- Operating income
- 72,000 USD
- Net income
- -4,601,000 USD
- Operating cash flow
- 10,524,000 USD